,Protective effects of compound FLZ, a novel synthetic analogue of squamosamide, on β-amyloid-induce

• 作 者: Fang FANG Geng-tao LIU
• 机 构: Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Pek
• 出 处: 中国药理学报（英文版）
• 发表日期: 2009年5期
• 关键词: compound FLZ β-amyloid mitochondrial dysfunction mitochondrial key enzymes cytoc

Aim: The aim of the present study was to assess the effects of N-[2-(4-hydroxyphenyl)ethyl]-2-(2,5-dimethoxyphenyl)-3-(3-methoxy-4-hydroxyphenyl) acrylamide (compound FLZ), a novel synthetic analogue of squamosamide, on the dysfunction of rat brain mitochondria induced by Aβ25-35 in vitro.Methods: Isolated rat brain mitochondria were incubated with aged Aβ25-35 for 30 min in the presence and absence of FLZ (1-100 μmol/L). The activities of key mitochondrial enzymes, the production of hydrogen peroxide (H2O2) and superoxide anion (O.-2), and the levels of glutathione (GSH) in mitochondria were examined. Mitochondrial swelling and the release of cytochrome c from mitochondria were assessed by biochemical and Weste blot methods, respectively.Results: Incubation of mitochondria with aged Aβ25-35 inhibited the activities of α-ketoglutarate dehydrogenase (α-KGDH),pyruvate dehydrogenase (PDH) and respiratory chain complex IV. It also resulted in increased H2O2 and O.-2 production,and decreased the GSH level in mitochondria. Furthermore, it induced mitochondrial swelling and cytochrome c release from the mitochondria. The addition of FLZ (100 μmol/L) prior to treatment with Aβ25-35 significantly prevented these toxic effects of Aβ25-35 on the mitochondria.Conclusion: FLZ has a protective effect against Aβ25-35-induced mitochondrial dysfunction in vitro.